SCHEMBL3199622

SCHEMBL3199622

CCCc1ccc(C(C)=O)s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
LMNA P02545 4/20 0.60
PRNP P04156 1/20 0.60
RECQL P46063 1/20 0.60
RXFP1 Q9HBX9 1/20 0.60
HPGD P15428 6/20 0.55
GSK3B P49841 1/20 0.48
TSHR P16473 4/20 0.46
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
HTT P42858 3/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3186013 0.89 ALDH1A1 (0.66) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL3193059 0.87 ALDH1A1 (0.69) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL3176363 0.85 LMNA (0.71) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL262537 0.84 DAO (0.50) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL4058053 0.84 ALDH1A1 (0.60) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL1798146 0.83 ALDH1A1 (0.56) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL10639931 0.82 ALDH1A1 (0.63) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL2690014 0.82 F2 (0.48) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL5887893 0.79 HPGD (0.53) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL10636804 0.79 LMNA (0.55) ALDH1A1LMNAPRNPRECQLRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114080389-A Nrf2 activating compound 千寿制药株式会社 2022-02-22 CN disclosed
US-7659411-B2 Process for producing 2-acylthiophene compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2010-02-09 US disclosed
CN-100455578-C Process for producing 2-acylthiophene compound SUMITOMO SEIKA CHEMICALS (JP) 2009-01-28 CN disclosed
US-20070149787-A1 Process for producing 2-acylthiophene compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2007-06-28 US disclosed
CN-1886396-A Process for producing 2-acylthiophene compound SUMITOMO SEIKA CHEMICALS (JP) 2006-12-27 CN disclosed
EP-1695972-A1 PROCESS FOR PRODUCING 2-ACYLTHIOPHENE COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2006-08-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149787-A1 Process for producing 2-acylthiophene compound AGPAT2, MOGAT2, TPST2 ALDH1A1 111/4885LMNA 4557/4885PRNP 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.